Protocol 5. HIV/AIDS treatment and care for injecting drug users




Substance dependence is a complex condition, with profound consequences for the health of drug users, for public health and for health care systems, particularly when the substances are injected.
The World Health Organization (WHO) and others have committed to scaling up access to highly active antiretroviral treatment (HAART and have confirmed that injecting drug users IDUs) should have equitable and universal access to HIV/AIDS prevention, treatment and care, including HAART (1). While this protocol has been produced specifically for countries in the WHO European Region, it should be equally useful for countries in other regions where injecting drug users require HIV/AIDS treatment and care.